Tunis and Pearson describe the objections raised by critics to the inclusion of comparative effectiveness research as part of President Obama’s health reforms and the concessions made so that the Patient-Centred Outcomes Research Institute could be included in the final legislation.1 Despite (possibly because of) the compromises made, the authors believe that the new institute “will prove to be enduring and highly influential.” Their belief seems to rest on the following frail foundations:
No takes yet. Share an insight, caveat, or question.
Nicholas Mays (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: